NO20083547L - Novel spiro[imidazolidine-4,3'-indole]-2,2",5' (1'H)-triones for treatment of conditions associated with vanilloid receptor 1 - Google Patents
Novel spiro[imidazolidine-4,3'-indole]-2,2",5' (1'H)-triones for treatment of conditions associated with vanilloid receptor 1Info
- Publication number
- NO20083547L NO20083547L NO20083547A NO20083547A NO20083547L NO 20083547 L NO20083547 L NO 20083547L NO 20083547 A NO20083547 A NO 20083547A NO 20083547 A NO20083547 A NO 20083547A NO 20083547 L NO20083547 L NO 20083547L
- Authority
- NO
- Norway
- Prior art keywords
- triones
- imidazolidine
- indole
- treatment
- conditions associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Nye forbindelser av formel I, hvor R1 og R2 er uavhengig halogen eller C1-3 halogenalkyl, X er etenyl eller etynyl, eller et salt derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77111906P | 2006-02-07 | 2006-02-07 | |
PCT/SE2007/000107 WO2007091947A2 (en) | 2006-02-07 | 2007-02-06 | Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083547L true NO20083547L (no) | 2008-11-05 |
Family
ID=38345567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083547A NO20083547L (no) | 2006-02-07 | 2008-08-14 | Novel spiro[imidazolidine-4,3'-indole]-2,2",5' (1'H)-triones for treatment of conditions associated with vanilloid receptor 1 |
Country Status (21)
Country | Link |
---|---|
US (2) | US20070185179A1 (no) |
EP (1) | EP2013215A4 (no) |
JP (1) | JP2009526043A (no) |
KR (1) | KR20080094906A (no) |
CN (1) | CN101415711A (no) |
AR (1) | AR059265A1 (no) |
AU (1) | AU2007212786B2 (no) |
BR (1) | BRPI0707423A2 (no) |
CA (1) | CA2641632A1 (no) |
CL (1) | CL2009000523A1 (no) |
IL (1) | IL192890A0 (no) |
NO (1) | NO20083547L (no) |
NZ (1) | NZ571070A (no) |
RU (1) | RU2421457C2 (no) |
SA (1) | SA07280027B1 (no) |
SG (1) | SG169387A1 (no) |
TW (1) | TW200801011A (no) |
UA (1) | UA93226C2 (no) |
UY (1) | UY30132A1 (no) |
WO (1) | WO2007091947A2 (no) |
ZA (1) | ZA200806407B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921576B2 (en) | 2011-10-19 | 2014-12-30 | Kowa Company, Ltd. | Spiroindoline compound, and medicinal agent comprising same |
TWI586668B (zh) * | 2012-09-06 | 2017-06-11 | 第一三共股份有限公司 | 二螺吡咯啶衍生物之結晶 |
CN108409746B (zh) * | 2018-05-15 | 2021-08-24 | 中山大学 | 一种含吡咯或吲哚并氮杂环烷结构的手性氧代螺环吲哚类化合物及其消旋体和制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE50332B1 (en) * | 1979-11-13 | 1986-04-02 | Ici Ltd | 1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof |
ZA806623B (en) * | 1979-11-13 | 1981-12-30 | Ici Ltd | Substituted indoline-2-one derivatives |
IE52879B1 (en) * | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
GB8331194D0 (en) | 1982-12-20 | 1983-12-29 | Ici Plc | Chemical process |
US4611062A (en) * | 1984-03-26 | 1986-09-09 | Imperial Chemical Industries Plc | Process for resolving certain spiro compounds |
WO1992007830A2 (en) | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
CN1361779A (zh) * | 1999-07-21 | 2002-07-31 | 阿斯特拉曾尼卡有限公司 | 新化合物 |
US7248802B2 (en) | 2002-11-27 | 2007-07-24 | Nokia Corporation | Distribution of a synchronization signal in an optical communication system |
TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
SE0301446D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | New Compounds |
KR20060027338A (ko) | 2003-06-12 | 2006-03-27 | 아스텔라스세이야쿠 가부시키가이샤 | 벤즈 아미드 유도체 또는 그 염 |
GB0326633D0 (en) * | 2003-11-14 | 2003-12-17 | Merck Sharp & Dohme | Therapeutic agents |
EP1771162B1 (en) | 2004-07-19 | 2013-06-05 | Xenia Pharma | Capsaicin inhibitors for the treatment of obesity-related disorders |
US20090076049A1 (en) * | 2006-02-07 | 2009-03-19 | Astrazeneca Ab | Novel Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 |
-
2007
- 2007-01-31 AR ARP070100412A patent/AR059265A1/es not_active Application Discontinuation
- 2007-01-31 TW TW096103591A patent/TW200801011A/zh unknown
- 2007-02-05 US US11/671,153 patent/US20070185179A1/en not_active Abandoned
- 2007-02-06 JP JP2008554186A patent/JP2009526043A/ja active Pending
- 2007-02-06 UY UY30132A patent/UY30132A1/es not_active Application Discontinuation
- 2007-02-06 CA CA002641632A patent/CA2641632A1/en not_active Abandoned
- 2007-02-06 AU AU2007212786A patent/AU2007212786B2/en not_active Ceased
- 2007-02-06 KR KR1020087019272A patent/KR20080094906A/ko not_active Application Discontinuation
- 2007-02-06 SG SG201100854-7A patent/SG169387A1/en unknown
- 2007-02-06 SA SA07280027A patent/SA07280027B1/ar unknown
- 2007-02-06 NZ NZ571070A patent/NZ571070A/en unknown
- 2007-02-06 CN CNA2007800125819A patent/CN101415711A/zh active Pending
- 2007-02-06 WO PCT/SE2007/000107 patent/WO2007091947A2/en active Application Filing
- 2007-02-06 EP EP07709323A patent/EP2013215A4/en not_active Withdrawn
- 2007-02-06 RU RU2008131905/04A patent/RU2421457C2/ru not_active IP Right Cessation
- 2007-02-06 BR BRPI0707423-9A patent/BRPI0707423A2/pt not_active IP Right Cessation
- 2007-06-02 UA UAA200809311A patent/UA93226C2/ru unknown
-
2008
- 2008-07-17 IL IL192890A patent/IL192890A0/en unknown
- 2008-07-23 ZA ZA200806407A patent/ZA200806407B/xx unknown
- 2008-08-14 NO NO20083547A patent/NO20083547L/no not_active Application Discontinuation
- 2008-11-20 US US12/274,837 patent/US7868181B2/en not_active Expired - Fee Related
-
2009
- 2009-03-05 CL CL2009000523A patent/CL2009000523A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2013215A2 (en) | 2009-01-14 |
KR20080094906A (ko) | 2008-10-27 |
ZA200806407B (en) | 2009-04-29 |
EP2013215A4 (en) | 2010-09-08 |
US20070185179A1 (en) | 2007-08-09 |
IL192890A0 (en) | 2009-02-11 |
RU2008131905A (ru) | 2010-03-20 |
CL2009000523A1 (es) | 2009-07-17 |
AU2007212786A8 (en) | 2010-05-06 |
CA2641632A1 (en) | 2007-08-16 |
BRPI0707423A2 (pt) | 2011-05-03 |
WO2007091947A3 (en) | 2007-10-04 |
NZ571070A (en) | 2011-07-29 |
AU2007212786B2 (en) | 2011-06-02 |
US7868181B2 (en) | 2011-01-11 |
RU2421457C2 (ru) | 2011-06-20 |
WO2007091947A8 (en) | 2008-08-07 |
AU2007212786A1 (en) | 2007-08-16 |
TW200801011A (en) | 2008-01-01 |
UA93226C2 (en) | 2011-01-25 |
AR059265A1 (es) | 2008-03-19 |
CN101415711A (zh) | 2009-04-22 |
US20090137650A1 (en) | 2009-05-28 |
JP2009526043A (ja) | 2009-07-16 |
SA07280027B1 (ar) | 2010-11-22 |
SG169387A1 (en) | 2011-03-30 |
WO2007091947A2 (en) | 2007-08-16 |
UY30132A1 (es) | 2009-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007091948A3 (en) | Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1 | |
EA039885B1 (ru) | Производные 6-амино-7-бицикло-7-деазапурина в качестве ингибиторов протеинкиназы | |
CO5700742A2 (es) | Moduladores del receptor de quimioquina ccr5 | |
DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
MY148504A (en) | Compounds which have activity at m? receptor and their uses in medicine | |
NO20075624L (no) | Nye histamin H3-reseptorligander og deres terapeutiske anvendelser | |
PE20090770A1 (es) | Derivados de benzoxazolona | |
WO2008094909A2 (en) | Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions | |
MX2009010909A (es) | Derivados de ftalazino y su uso como medicamento para tratar el cancer. | |
NO20075768L (no) | Hydroksybenzamidderivater og deres anvendelse som inhibitorer av HSP90 | |
NO20075406L (no) | Pyrimidindionerivater som prokineticin-2-reseprorantagonister | |
Zhou et al. | Synthesis and insecticidal activities of 2, 3-dihydroquinazolin-4 (1H)-one derivatives targeting calcium channel | |
NO20083547L (no) | Novel spiro[imidazolidine-4,3'-indole]-2,2",5' (1'H)-triones for treatment of conditions associated with vanilloid receptor 1 | |
WO2008155670A3 (en) | Arylamide pyrimidone compounds | |
MX2009012383A (es) | Derivados de arilamida pirimidona para el tratamiento de enfermedades neurodegenerativas. | |
US20110065725A1 (en) | Triazole amide derivatives for use in therapy | |
MA32947B1 (fr) | Piperidines substitues par aroylamino et heteroaroylamino comme inhibiteurs de glyt-1 | |
NO20051009L (no) | Syntese av indoliziner | |
CA2605144C (en) | Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators | |
JP2022547200A (ja) | 三環系構造を有する芳香複素環式化合物、およびその調製方法と適用 | |
CN110054622A (zh) | 噁二唑类衍生物、其制备方法及其在医药上的应用 | |
ATE388945T1 (de) | Benzoxazolderivate und deren verwendung als adenosinrezeptorliganden | |
AR043964A1 (es) | Derivados de 4- ( 2-fenilsulfanil-fenil) 1,2,3,6-tetrahidropiridina como anhibidores de la recaptacion de serotonina | |
CN114805199A (zh) | 一种苯环衍生物及其在医药上的应用 | |
ATE468118T1 (de) | Bis-1,2,3,4-tetrahydroisochinolinderivate und ihre verwendung als pharmazeutika |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |